AbbVie PESTEL analysis 2026 examines the political, economic, social, technological, environmental and legal factors affecting the company based on its 2025 Annual Report and Form 10-K.

AbbVie business strategy in 2026 focuses on scaling Skyrizi and Rinvoq, expanding neuroscience, replenishing its pipeline, broadening indications and sustaining innovation beyond the Humira patent cliff.

BlackRock PESTEL analysis 2026 examines the political, economic, social, technological, environmental and legal factors affecting the company based on its 2025 Annual Report and Form 10-K.